Spring Pharma: Shkreli, Retrophin Illegally Stifled Thiola Generics

Drug Industry Daily
A A
Spring Pharmaceuticals sued incarcerated ex-pharma CEO Martin Shkreli and his former biopharmaceutical company Retrophin for blocking generics of its kidney stone drug Thiola.

To View This Article:

Login

Subscribe To Drug Industry Daily